These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16975)

  • 61. Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.
    Michiels JJ; van Vliet HH; Berneman Z; Schroyens W; Gadisseur A
    Acta Haematol; 2009; 121(2-3):167-76. PubMed ID: 19506363
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor.
    Allain JP; Cooper HA; Wagner RH; Brinkhous KM
    J Lab Clin Med; 1975 Feb; 85(2):318-28. PubMed ID: 234499
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
    Green D; Potter EV
    J Lab Clin Med; 1976 Jun; 87(6):976-86. PubMed ID: 778313
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Assay of ristocetin cofactor: experience with a platelet counting technique.
    Bird AR; Sacks R; Smith A
    Med Lab Sci; 1984 Jan; 41(1):38-45. PubMed ID: 6609295
    [No Abstract]   [Full Text] [Related]  

  • 65. On the characterization of acquired inhibitors to ristocetin induced platelet aggregation found in patients with von Willebrand's disease.
    Egberg N; Blombäck M
    Thromb Res; 1976 Nov; 9(5):527-31. PubMed ID: 1087055
    [No Abstract]   [Full Text] [Related]  

  • 66. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen.
    Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
    J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antibody nature of circulating inhibitor of plasma von Willebrand factor.
    Stratton RD; Wagner RH; Webster WP; Brinkhous KM
    Proc Natl Acad Sci U S A; 1975 Oct; 72(10):4167-71. PubMed ID: 812091
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Abnormality of glycoprotein Ib in two cases of "pseudo"-von Willebrand's disease.
    Bryckaert MC; Pietu G; Ruan C; Tobelem G; Girma JP; Meyer D; Larrieu MJ; Caen JP
    J Lab Clin Med; 1985 Oct; 106(4):393-400. PubMed ID: 2931492
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Von Willebrand factor: gene dosage relationships and transfusion response in bleeder swine--a new bioassay.
    Griggs TR; Webster WP; Cooper HA; Wagner RH; Brinkhous KM
    Proc Natl Acad Sci U S A; 1974 May; 71(5):2087-90. PubMed ID: 4546019
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Von Willebrand Factor (VIIIVWF) in lyophilized Factor VIII concentrates.
    McCue MJ; Brossoit AD; Marmer DJ; Head DR
    Am J Hematol; 1980; 9(1):39-42. PubMed ID: 6776806
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ristocetin-Willebrand factor activity in dog plasma.
    Johnstone IB; Lotz F
    Can J Physiol Pharmacol; 1980 Sep; 58(9):1128-34. PubMed ID: 6970064
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Lack of von Willebrand factor, factor VIII related antigen and factor VIII coagulant response to human growth hormone infusion in type 2 diabetes mellitus.
    Grecu EO; Sheikholislam BM; Abildgaard CF
    Am J Med Sci; 1984; 287(2):3-6. PubMed ID: 6424471
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Inhibition of Willebrand factor in von Willebrand disease.
    Maragall S; Castillo R; Ordinas A; Liendo F; Rodríguez M
    Thromb Res; 1979; 14(2-3):495-500. PubMed ID: 312541
    [No Abstract]   [Full Text] [Related]  

  • 75. A simplified assay for von Willebrand factor.
    Rivard GE; Daviault MB
    Thromb Res; 1978 Apr; 12(4):677-80. PubMed ID: 307285
    [No Abstract]   [Full Text] [Related]  

  • 76. Support of ristocetin-induced platelet aggregation by procoagulant-inactive and plasmin-cleaved forms of human factor VIII/von Willebrand factor.
    Andersen JC; Switzer ME; McKee PA
    Blood; 1980 Jan; 55(1):101-8. PubMed ID: 6444272
    [No Abstract]   [Full Text] [Related]  

  • 77. Factor VIII in von Willebrand' disease.
    Irwin JF
    Semin Thromb Hemost; 1975 Oct; 2(2):85-104. PubMed ID: 798271
    [No Abstract]   [Full Text] [Related]  

  • 78. Effect of exercise on F VIII-complex: proportional increase of ristocetin cofactor (Von Willebrand factor) and F VIII-AGN, but disproportional increase of F VIII-AHF.
    Stibbe J
    Thromb Res; 1977 Jan; 10(1):163-8. PubMed ID: 300513
    [No Abstract]   [Full Text] [Related]  

  • 79. Influence of high ionic strength buffers on factor VIII/von Willebrand factor from different species.
    Lavergne JM; Meyer D; Jenkins CS; Obert B; Larrieu MJ
    Thromb Res; 1978 Sep; 13(3):409-18. PubMed ID: 311086
    [No Abstract]   [Full Text] [Related]  

  • 80. Von Wollebrand's disease with normal Factor VIII activity in a homozygote.
    Holmberg L; Rasović N; Nilsson IM
    Haemostasis; 1974; 3(4):237-46. PubMed ID: 4549210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.